Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$6.77 USD
+0.27 (4.15%)
Updated Sep 26, 2025 04:00 PM ET
After-Market: $6.78 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LXEO 6.77 +0.27(4.15%)
Will LXEO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LXEO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LXEO
New Uptrend appears for LXEO after 0.61% move
LXEO forms Expansion Breakout on September 25
12 Health Care Stocks Moving In Wednesday's Intraday Session
LXEO's price rises by 0.75% on September 23, though its technical setup remains stable.
20 Day Moving Average Support appears for LXEO after 3.11% move